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Abstract
Background: Negative variation in the management of patients with the same clinical condition is
frequent, and affects quality of care. Recent studies indicate that single interventions are not an effective
solution. We aim to demonstrate that a multifaceted strategy can favor the introduction of research into
practice, and to assess its long-term effects on a set of common medical conditions exhibiting significant
negative variation at our institution.
Methods: The strategy, devised and agreed upon by a multidisciplinary group, was first applied to one
relevant medical condition – cerebral ischemic stroke. To test its effectiveness a quasi-experimental study
was conducted, comparing an intervention group with historical controls. After validation the strategy was
extended to other pathologies, and its long-term effect measured using evidence-based quality indicators.
Adherence to each indicator was determined prospectively on a six-month basis for a period of at least
two consecutive years. Measures are expressed as proportions with 95% confidence intervals.
Results: Validation findings demonstrated that the strategy improved compliance with scientific evidence:
the percentage of patients who received a CT scan within 24 hours of hospital presentation rose from
56% to 75%, (χ2 = 7.43 p < 0.01); admissions to selected wards increased from 45% to 64%, (χ2 = 7.81 p
< 0.01); the number of physical medicine visits within 24 hours of the request grew from 59% to 91% (χ2
= 14,40 p < 0.001). Over a four-year period the program was gradually applied to 14 medical conditions.
Except for 3 cases, compliance with the pathway, i.e. number of eligible patients for whom data on the
care process is collected, was above the minimum requirement of 75%. Indicator adherence generally
exhibited a positive trend, though variability was observed both among different conditions and between
different semesters for the same pathology.
Conclusion: According to our experience, incorporation of research into practice can be favored by
systematically applying a shared, multifaceted strategy, involving multidisciplinary teams supported by
central coordination. Institutions should device a tailor-made approach, should train personnel on
implementation strategies, and create cultural acceptance of change. Just like for experimental trials,
human and economic resources should be allocated within health care services to allow the achievement
of this objective.
Published: 19 September 2005
BMC Health Services Research 2005, 5:62 doi:10.1186/1472-6963-5-62
Received: 09 May 2005
Accepted: 19 September 2005
This article is available from: http://www.biomedcentral.com/1472-6963/5/62
© 2005 Caminiti et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Health Services Research 2005, 5:62 http://www.biomedcentral.com/1472-6963/5/62
Page 2 of 11
(page number not for citation purposes)
Background
A large variance in the utilization of health technology
(concerning both drugs, equipment, and medical/surgical
procedures as well as the organizational and support
framework for such performances) is increasingly evident,
putting patients at risk of receiving unnecessary care, or of
being deprived of performances already proven effective
[1-3]. This awareness has made quality of care a central
issue [4]. In the past few years various approaches to this
phenomenon have been developed, suggesting alternative
methodological solutions involving different professional
groups. Quality assurance (QA), technology assessment
(TA), clinical epidemiology (CE), and continuous quality
improvement (CQI), are just a few of the disciplines
involved in the critical and constructive evaluation of clin-
ical practice. The main and widely accepted indications
suggested by research in this field [5,6] are the following:
1) in order to ensure effectiveness, organizational, socio-
cultural, and structural aspects must be taken into
account; 2) in order to improve clinical practice the
sources of problems must be identified, and all parties
must be actively involved; 3) in order to verify and
improve the quality of care, accurate local data must be
readily available. Following the above-mentioned indica-
tions, we have decided to develop and implement at our
hospital a multifaceted strategy, comprising the creation
and application of integrated care pathways (ICPs), and
the monitoring of quality indicators (QIs).
In this article we first describe this strategy and aim to
demonstrate that it improves adherence to scientific evi-
dence and consequently reduces negative deviations in
patients with stroke. We then describe our experience over
a four-year period with the gradual extension of the strat-
egy to other eligible medical conditions and the testing of
its long-term effect.
Methods
The study began in June 2000 and was implemented at
one of the largest Italian health care facilities, with 1420
beds (of which 330 for out-patients and 90 for long-term
care), and over 60,000 admissions per year.
This initiative was carried out as part of a project spon-
sored by the Italian Ministry of Health, and was designed
in order to provide health planners with indications on
factors which favor or hinder the routine use of clinical
"best practice", in a natural context of a health care facil-
ity, and to suggest the rationale for new intervention
studies.
Strategy's definition and validation
The strategy comprises a sequence of interventions, each
designed to remove barriers which have been demon-
strated by preceding studies to hinder EBM practice [2]. It
was developed with the involvement of various profes-
sionals: clinicians, nurses, administrators, epidemiologist,
sociologist, patients' representative; this factor has made it
possible to devise a shared program, suited to our local
reality. Integrated care pathways, quality indicators and
relative audit were chosen as tools necessary to health care
workers to define the best process in the workplace and
monitor variation.
ICPs' creation and application
Integrated care pathways are structured multidisciplinary
care plans which detail essential steps in the care of
patients with a specific clinical problem [7]. What follows
is the description of three main aspects of the process fol-
lowed for the creation and application of ICPs at our insti-
tution, outlined in detail in Figure 1 along with the
relative mean times.
1. Multidisciplinary team (MT) creation
Motivated clinicians and nurses involved with the condi-
tion join the MT voluntarily. While the MT should not be
too large, it is important that all departments involved
with the pathology be represented. The members will then
appoint the coordinator – a key figure for the success of
the pathway.
2. Agreement on objectives and actions
The MT meets regularly to identify key aspects and discuss
local problems of the process of care. The team's discus-
sion is based on the evidence gathered through a careful
literature analysis. This will eventually lead to the creation
of a document which contains the ICP's objectives,
required interventions, the description of the pathway
through time-task matrices, and the data collection sheet
used for the analysis of the care process. This document
will be subject to periodical reviews and modified when
Phases of ICP development and relative mean times Figure 1
Phases of ICP development and relative mean times.
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appropriate. The document is disseminated to all profes-
sionals involved with the pathology in question, in order
to build consensus and favor its application.
3. Implementation phase
It's a sort of experimental stage, necessary to educate
health care professionals on the use of the ICP; during this
phase the data, gathered with an ad hoc data collection
sheet, will be used to describe the care process, and MT
compliance, i.e. the number of eligible patients for whom
the data collection sheet is filled out, will be verified; this
value is considered acceptable if greater than 75% [7].
Development of indicators and analysis through audit
Based on the analysis of the information collected with
paper forms, during the implementation phase, and on
detected variation, each member of the MT will suggest
possible quality indicators. The MT will discuss them and
assess them against criteria such as validity (strength of
evidence), reliability and feasibility of data collection
(they should be easy to retrieve, calculate and interpret),
and sensitivity to change [8]. The indicators which best
meet the criteria, about 3–6, will be chosen, and form the
minimum set of QIs, gathered prospectively using an elec-
tronic record [9] and monitored to measure adherence to
scientific evidence. To ensure the correct interpretation of
observed variations, inclusion and exclusion criteria for
each QI are explicitly defined and considered during data
processing.
Multiprofessional audit is performed regularly (approxi-
mately every 3 months) in order to discuss any negative
deviations, to determine the causes, and act upon them if
needed [7,9-13]. This should ensure that improvement is
gradually achieved and maintained.
Study design and statistical analysis for validation
The above-mentioned strategy was first applied to one rel-
evant medical condition – cerebral ischemic stroke – in
order to test its effectiveness. We opted for a quasi-experi-
mental design, a controlled study in which an interven-
tion is assigned without the use of randomization [14]. To
determine whether the introduction of the intervention
had changed behavior in terms of improved adherence to
scientific evidence, we compared clinical records of all
patients with cerebral ischemic stroke consecutively hos-
pitalized during 2 homogeneous periods, preceding and
following the strategy's introduction. The size of the con-
sidered sample, about 100 cases per group, was adequate
to detect a difference of at least 20%, with significance
level α = 0.05 and power 1-β = 0.80. The comparison
between proportions was examined using the χ2 test [15].
We considered P values < 0.05 to be significant, P values
< 0.01 strongly significant and P values < 0.001 extremely
significant. Data were processed using the SAS System
(version 8.1).
Strategy's extension and long-term effects
Following the validation phase, the strategy was gradually
applied to other medical conditions chosen according to
the following criteria: high admission frequency (at least
100 admissions/year), large variations in clinical practice
affecting patient outcome, and high level of interest
among local staff. Frequency and variation are verified
through the analysis of discharge summaries, clinical
records, or studies conducted at a local level for other
purposes.
The activity of the MTs is coordinated by the Support
Panel (SP). This group – made up of 1 epidemiologist, 1
professional nurse, 1 data manager, and 1 bibliographic
researcher – verifies that the chosen medical conditions
meet the selection criteria, tests compliance with the pro-
gram, intervenes in the case of conflict, and provides sup-
port to the management in the collection and analysis of
data and literature.
For the medical conditions which completed all the steps
required by the multifaceted strategy, we recorded a min-
imum set of quality indicators to monitor the strategy's
long-term effect. Data analysis was carried out following
the methodology commonly applied in descriptive obser-
vational studies [14]. The analysis consisted in the pro-
spective collection of specific indicators, which must be
gathered for all eligible patients (following the inclusion
criteria established by the multidisciplinary team) consec-
utively admitted to hospital in a given period (the same
dynamic target population). The analysis of such data
enables to assess adherence to key aspects of the care proc-
ess, both in terms of constant improvement and mainte-
nance of improvement overtime once it has been
achieved. We determined adherence to each indicator on
a six-month basis for a period of at least 2 consecutive
years (long-term effect). Each measure is expressed as a
proportion with relative 95% confidence interval.
Results
Strategy's validation
We compared two periods: the first 6 months of 2001,
when the intervention was in use, and the corresponding
period of the previous year, when it was not. Trained per-
sonnel examined 224 clinical records of eligible patients
discharged with a primary diagnosis of cerebral ischemic
stroke. The comparison employed the following 3 quality
indicators, adapted from the indications established in
1999 by the American Heart Association/American Col-
lege of Cardiology [16]:BMC Health Services Research 2005, 5:62 http://www.biomedcentral.com/1472-6963/5/62
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- Performance of a CT scan within 24 hours of hospital
presentation;
- Patient admission to dedicated wards;
- Timely involvement of the rehabilitation team
The results of the comparison between the intervention
and control groups, carried out to demonstrate improve-
ment of behavior, are the product of the following specific
interventions agreed upon by the MT (table 1):
- Cerebral CT scan is crucial to determining the type of
stroke and consequently planning the correct therapy
[17]. Earlier, patients with suspected stroke usually under-
went CT scan in the admission ward, often experiencing
important delays, while in some cases the test was not per-
formed. It was therefore decided to provide CT scans for
suspected stroke in the emergency department. After the
intervention the percentage of patients who received a CT
scan within 24 hours of hospital presentation rose from
56% to 75%, (χ2 = 7.43 p < 0.01).
- At our institution, stroke patients used to be hospitalized
according to bed availability, which resulted in high dis-
persion. Considering the great importance of specialized
stroke care, as demonstrated in the literature [18], the ICP
requires that all subjects presenting to the ER with sus-
pected stroke be reported by telephone to one of the refer-
ring physicians who will be in charge of the patient.
Consequently, admissions of stroke patients to selected
wards increased from 45% to 64%, (χ2 = 7.81 p < 0.01).
- Prior to the intervention, physical medicine evaluation
and rehabilitation were not always promptly initiated,
mostly due to a lack of communication between the wards
and the physical medicine department. Since early inter-
vention is central in improving disability and quality of
life [18], a referring physical medicine physician was cho-
sen who is immediately informed via fax when a new
stroke patient is admitted to hospital. This will enable the
rapid provision of an individualized evaluation and reha-
bilitation program. After the introduction of this measure
the number of patients with rehabilitative indication seen
by the rehabilitation team within 24 hours grew from
59% to 91% (χ2 = 14,40 p < 0.001).
Strategy's extension and long-term effects
Over a four-year period the strategy was gradually applied
to 14 medical conditions, involving nearly 150 health
care workers, and allowing the hospital management of
over 7000 patients/year to be verified.
The 14 conditions have reached different stages, depend-
ing on the time they were included in the program, and
also on factors related to the individual MTs. Table 2 pro-
vides for each pathway initiation date, MT composition,
number of eligible patients/year, and MT compliance. The
latter has been recorded for 13 out of 14 ICPs – in June
2004 the one on Pulmonary Thromboembolism had yet
to begin implementation. Except for the ICPs on Breast
Cancer, Supraventricular Tachiarrhythmias, and Pediatric
Head Injury (53%, 55%, and 62% respectively), compli-
ance was good, reaching optimal rates for Liver Cirrhosis
(94%), Stroke (89%), Pediatric Pneumonia and
Melanoma (88%), Child Delivery (86%), and chronic
obstructive pulmonary disease (COPD) (84%).
By June 2004, indicators had been defined for 7 condi-
tions. For 5 of those (Stroke, Chest Pain, COPD, Child
Delivery, Lung Cancer) the effect of the strategy has been
monitored for at least 2 years; for the remaining two (Liver
Cirrhosis and Pediatric Pneumonia) indicators have been
monitored since the second semester of 2003, and thus
are not included in our long-term analysis. For three con-
ditions (Supraventricular Tachiarrhythmias, Breast Cancer
and Pediatric Head Injury) the minimum set of indicators
had not been measured. Hip Arthroplasty, Melanoma and
Non-Hodgkin Lymphomas had completed their imple-
mentation phase, and the MTs were working on defining
the quality indicators to begin monitoring.
Table 3 shows the trend of adherence to each indicator for
five semesters, the two semesters of 2002 and 2003, and
the first semester of 2004, except for Lung Cancer for
which only 4 semesters are shown because implementa-
tion was delayed.
Some indicators exhibit extremely high adherence, con-
stant through time; for instance, percentage of borderline
lung cancer cases discussed by the multidisciplinary team,
performance of a CT scan in stroke patients, and appropri-
ate length of stay (LOS) for COPD patients according to
severity, have never fallen below 90% in the observed
semesters.
Other indicators began with a low, or fairly low adherence
and then exhibited considerable improvements; for
instance, the percentage of eligible patients receiving
spirometry rose from 56% to 96%. The same positive
trend was observed for indicators relating to the appropri-
ateness of admission: stroke patients admitted to a dedi-
cated ward (63%–82%); patients with chest pain
hospitalized in the appropriate ward according to pain
characteristics (64%–77%); and COPD patients hospital-
ized in the appropriate ward according to severity (64%–
86%).
Finally, for some indicators adherence rates are still low
compared to the standards found in the literature; forBMC Health Services Research 2005, 5:62 http://www.biomedcentral.com/1472-6963/5/62
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example, the percentage of cesarean sections (CSs) (39%
in the last semester) remains far above the WHO recom-
mendation of a 15% rate. Analogously, the percentage of
lung cancer patients included in the ICP within 2 weeks of
the first X-ray, on which suspicion is based, remains fairly
poor in the 4 analyzed semesters.
For further clarity, trends for five medical conditions are
portrayed graphically in Figure 2.
Discussion
In order to improve adherence to evidence-based medi-
cine at our hospital, we applied a planned strategy
comprising a combination of interventions, each address-
Table 1: Pre-post comparison of compliance with QIs for Cerebral Ischemic Stroke
PRE-INTERVENTION POST-INTERVENTION
INDICATOR N. patients assessed Value (95%CI) N. patients assessed Value (95%CI)
Performance of CT scan within 24 h of hospital 
presentation
110 56% (47–65) 114 75% ++ (67–83)
Admission to a dedicated ward 110 45% (36–54) 114 64% ++ (55–73)
Early intervention of the rehabilitation team * 57 59% (46–72) 64 91% +++ (84–98)
Level of test significance χ2
+ p < 0.05
+ + p < 0.01
+ + + p < 0.001
* Patients for whom rehabilitation was indicated.
Table 2: Integrated care pathways in use at our institution
ICP Initiation Date Eligible/Year+ MT Composition MT Compliance ++
Cerebral Ischemic 
Stroke
June 2000 220–230 2 emergency medicine physicians, 1 geriatrist, 1 physical 
medicine physician, 1 neurologist, 1 neuroradiologist, 2 
internists, 1 psychiatrist, 1 physiotherapist, 2 nurses.
89%
Pediatric Head Injury June 2001 100–110 1 neuropsychiatrist, 2 pediatricians, 1 radiologist, 2 nurses. 62%
Chest Pain June 2001 1800–2000 3 cardiologists, 1 cardiosurgeon, 2 emergency medicine 
physicians, 2 internists, 3 nurses.
79%
COPD June 2001 430–450 3 pulmonologists, 1 emergency medicine physician, 1 
geriatrist, 1 physical medicine physician, 2 nurses.
84%
Child Delivery June 2001 2000–2100 3 gynecologists, 1 pediatrician, 1 obstetrician, 1 nurse. 86%
Lung Cancer June 2001* 200–220 3 pulmonologists, 2 thoracic surgeons, 1 oncologist, 1 
radiologist, 1 radiotherapist, 1 physical medicine physician, 1 
pathologist, 2 nurses.
77%
Breast Cancer December 2001 320–340 2 oncologists, 3 surgeons, 1 plastic surgeon, 1 radiologist, 1 
radiotherapist, 1 pathologist, 1 biologist, 1 nurse.
53%
Pediatric Pneumonia December 2001 110–130 6 pediatricians, 1 neonatologist, 1 radiologist, 2 nurses. 88%
Liver Cirrhosis December 2001 470–490 2 gastroenterologists, 3 infective disease physicians, 2 nurses. 94%
Supraventricular 
Tachiarrhythmias
March 2002 680–700 3 cardiologists, 4 internists, 2 emergency medicine physicians, 
1 nurse.
55%
Hip Arthroplasty October 2002 360–380 4 orthopedists, 1 radiologist, 1 physical medicine physician, 1 
anesthetist, 1 hematologist, 2 nurses.
82%
Melanoma January 2003 110–130 3 dermatologists, 2 plastic surgeons, 1 nuclear medicine 
physician, 2 oncologists, 1 general surgeon, 1 pathologist, 1 
nurse.
88%
Non-Hodgkin 
Lymphomas
June 2003 90–110 1 oncologist, 1 radiotherapist, 1 radiologist, 2 hematologist, 1 
nuclear medicine physician, 1 surgeon, 2 internists, 1 nurse
77%
Pulmonary 
thromboembolism
April 2004 190–210 1 emergency medicine physician, 2 pulmonologists, 1 nuclear 
medicine physician, 2 internists, 1 geriatrist, 1 cardiologist, 1 
radiologist
*
* For this pathway the implementation phase was not completed by June 2004, thus data are not available.
+ Eligible/Year: number of patients who meet the inclusion criteria set forth in the ICP document.
++ MT Compliance: number of eligible patients for whom the data collection sheet is filled out; this value is considered acceptable if greater than 
75%.BMC Health Services Research 2005, 5:62 http://www.biomedcentral.com/1472-6963/5/62
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Table 3: Trend of adherence to each indicator by semester
CONDITION INDICATOR 1st semester 
2002 Percentage 
(95%CI)
2nd semester 
2002 Percentage 
(95%CI)
1st semester 
2003 Percentage 
(95%CI)
2nd semester 
2003 Percentage 
(95%CI)
1st semester 
2004 Percentage 
(95%CI)
STROKE CT scan performed within 24 
hours of hospital 
presentation[17]
91%
(86–97)
90%
(84–96)
96%
(92–100)
96%
(93–99)
93%
(88–98)
Patients admitted to a dedicated 
ward[18]
63%
(56–71)
74%
(67–81)
81%
(75–87)
80%
(74–86)
82%
(75–89)
Visits by the physical medicine 
specialist within 24 hours of 
request for patients with 
rehabilitative indication [18]
78%
(69–87)
65%
(55–75)
94%
(89–99)
82%
(74–90)
75%
(66–84)
Patients transferred to a post-
acute care facility according to 
their clinical indications [41]
89%
(78–100)
78%
(64–91)
80%
(72–89)
79%
(72–86)
73%
(64–82)
Psychiatric tests (GDS) 
administered to patients eligible 
for the test [42]
67%
(58–78)
57%
(46–69)
73%
(64–83)
74%
(65–83)
75%
(66–84)
Patients discharged alive who 
underwent 1 follow-up visit 1–3 
months after the onset of stroke 
[16]
57%
(47–68)
67%
(57–76)
80%
(72–88)
69%
(60–78)
74%
(65–83)
CHEST PAIN Patients discharged from the ED 
and readmitted to hospital 
within 1 month [43]
3.2%
(1–6)
1.4%
(0–3)
0.5%
(0–2)
1.9%
(0–4)
0%
Hospitalized patients admitted 
to the appropriate ward 
according to pain characteristics 
[44]
64%
(61–67)
61%
(58–64)
81%
(78–84)
73%
(70–76)
77%
(74–80)
Patients with AMI admitted to 
the coronary ICU within 60 
minutes of hospital presentation 
[45]
63%
(55–70)
65%
(58–72)
77%
(70–84)
70%
(63–77)
76%
(69–83)
Diagnoses of AMI in the 
discharge summaries 
inconsistent with clinical records 
[46]
8%
(5–11)
9%
(5–13)
7%
(4–10)
7%
(4–10)
5%
(2–8)
COPD Patients hospitalized in the 
appropriate ward according to 
severity [47]
64%
(57–71)
62%
(55–69)
75%
(69–81)
92%
(88–96)
86%
(81–91)
Patients eligible for spirometry 
who underwent spirometry [48]
56%
(49–63)
49%
(41–56)
92%
(88–96)
92%
(88–96)
96%
(93–99)
Patients with MRC dyspnea 
grade >= 3 on admission who 
improved on discharge [49]
86%
(79–92)
83%
(77–90)
91%
(86–96)
88%
(82–94)
87%
(81–93)
Patients hospitalized for the 
appropriate number of days 
according to clinical severity [50]
93%
(88–98)
98%
(95–100)
96%
(93–100)
94%
(89–99)
97%
(94–100)
CHILD 
DELIVERY
Cesarean sections on the total 
number of child deliveries [51]
41%
(38–44)
41%
(39–44)
35%
(32–38)
39%
(36–42)
39%
(36–42)
Elective cesarean sections for 
women with previous cesarean 
section without 
contraindications to vaginal 
delivery [52]
66%
(57–75)
60%
(51–69)
45%
(36–54)
64%
(55–73)
56%
(47–65)
Cesarean sections performed 
because of the woman's 
psychological refusal of vaginal 
delivery [53]
25%
(18–32)
17%
(11–23)
18%
(12–24)
15%
(10–20)
20%
(15–25)
LUNG 
CANCER
Patients included in the ICP 
within 2 weeks of the first X-ray 
[54]
53%
(43–62)
55%
(43–67)
61%
(51–71)
62%
(51–73)
Patients diagnosed within 4 
weeks since ICP inclusion [54]
73%
(64–82)
73%
(63–83)
78%
(69–87)
62%
(51–73)BMC Health Services Research 2005, 5:62 http://www.biomedcentral.com/1472-6963/5/62
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ing specific barriers to change (from professional, socio-
cultural, and organizational viewpoints); we have
demonstrated through a quasi-experimental study the
effectiveness of this strategy. The improvement trend we
demonstrate is consistent with the findings reported by
Kwan et al in a very recent before-after study on the appli-
cation of a Stroke pathway, concerning the indicators on
timely CT scan performance and early involvement of the
rehabilitation team [19].
The execution of the program we propose is complex (it
requires meetings, debates, data collection, etc.), but so is
the process of incorporation of evidence into practice; in
fact, despite publication of several management guide-
lines in virtually any medical field, the literature shows
that adherence to EBM indications is often poor [2,20-
22]. The biggest obstacle seems to be the perception of
guidelines as tools distant from the reality in which one
operates, and the large amount of information often con-
tained in guidelines, which clinicians have no time to
digest [20,23]. The picture is complicated by the gap
between those who practice and those who manage
health care, whereby the introduction of new technolo-
gies/tests and the implementation of change is sometimes
left to the initiative of individual professionals, or, con-
versely, allows administrators to activate or cancel proce-
dures without assessing the effects of their decisions at a
local level with those directly involved (health care work-
ers and users). We tried solving these problems by creating
a constant debate between administrators and health care
workers, from the initial stages of the improvement strat-
egy's definition.
We have demonstrated the strategy's capability to improve
adherence to scientific evidence through a quasi-experi-
mental study with historical controls, and not a
randomized trial. RCTs are the gold standard for testing
effectiveness, however in our case this design would have
posed a number of methodological issues. For complex
interventions aiming to change behavior, like ours, rand-
omization by individual patients is not feasible and clus-
ter randomization, by doctor or practice, is usually
advised [24]. This approach, however, would have been
extremely complex to take in our study, because the strat-
egy in question involves multiple organizational levels
(Emergency Department, Internal Medicine wards, Neu-
rology, Rehabilitation, Radiology service). Furthermore,
since the intervention's effectiveness depends on the sub-
jects' active participation and on their choices, random
allocation may lessen its effect, and a clinical trial would
in fact be inappropriate [25,26].
The analysis of clinical records as a means of validating
the program also has some well-known limitations
(exhaustivity, accuracy, etc.), however it offers the great
advantage of allowing timely access to the information
needed to documenting an intervention's impact using a
historical control. A possible bias may exist in the inter-
pretation of the measured effect, which may be due to
greater accuracy of documentation rather than to a real
change in care. However, since a pathway's success is
strictly related to the quality and quantity of available
information on the patients' characteristics and the tests
they undergo, the appropriate management of clinical
information is part of our work's objective.
Our work concerns the adoption of an improvement strat-
egy in a large hospital involving a set of common medical
conditions, and its long-term effectiveness. Studies on the
subject generally focus on a single condition, or on a few
easy-to-standardized pathologies [27-34]. Instead, our
work concerns the use of 14 ICPs, of which 77% exhibit
good compliance with the strategy. Noteworthy is also the
number of patients, approximately 7000/year, whose
hospital management is verified through: the analysis of
data prospectively collected, the comparison with the
most recent scientific indications, and the discussion of
deviations by a group of experts directly involved in the
management of the condition. What makes our experi-
ence different is that it focuses on the strategy's effective-
ness in the long-run, while research on ICPs found in the
literature generally reports on short-term findings. A very
recent Australian study [35] does focus on the long-term
effect of ICP use, but the number of patients included in
the analysis is quite small.
Staged patients [55] 89%
(83–95)
97%
(93–100)
93%
(88–98)
96%
(92–100)
Patients transferred to the 
intensive care unit for the first 
24 hours after surgery [56]
93%
(87–99)
87%
(77–97)
81%
(70–92)
86%
(76–96)
Patients who underwent surgery 
according to eligibility criteria 
[55]
91%
(84–98)
97%
(93–100)
88%
(81–95)
91%
(85–97)
Borderline cases discussed by 
the multidisciplinary group [55]
100% 100% 100% 100%
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Trend of adherence to each indicator by semester Figure 2
Trend of adherence to each indicator by semester. For each condition the proportion of patients receiving key inter-
ventions after the introduction of the multifaceted strategy is displayed. See text for the full description of indicators and for 
bibliographic references.
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Despite some variability, data generally demonstrate a
positive trend, showing improvements for most indica-
tors with fairly frequent drops in both second semesters,
which most probably reflect the greater difficulties
encountered during the summer holiday season, when
personnel is reduced, thus affecting the provision of serv-
ices. The measures we adopted to achieve change in
behavior were both educational (critical literature analy-
sis, sharing and dissemination of the ICP, systematic clin-
ical audits, etc.), and organizational/managerial
(performance of CT scans in the emergency department,
rapid involvement of the rehabilitation team via fax, use
of a portable spirometer for bedridden patients, etc.). As
also noted by Panella et al in a recent Italian experience
with the application of an ICP program [36], constant dia-
logue within MTs and between managers and clinicians,
based on variance analysis, is essential to ensure best clin-
ical practice.
The employment of this strategy is not easy, and some
medical conditions have encountered greater difficulties
than others. The ICP on Breast Cancer has been inactive
since September 2002; though it was initiated in Decem-
ber 2001, it has not yet completed its implementation
phase, and indicators have not yet been defined. This
pathway's problems are mostly caused by the instability
consequent to the change of the director of the Oncology
Department, which led to the lack of a leading figure in
the multidisciplinary group, an essential aspect for
improvement of clinical practice [7]. The ICP on Pediatric
Head Injury was also inactive since January 2002. Indica-
tors have been defined but never applied. The main obsta-
cle for this ICP seems to be the concern of many
physicians of losing their professional freedom, also fear-
ing possible ethical and legal implications in the care of
children [37]. The ICP on Supraventricular tachiarrhyth-
mias, which was in its implementation phase, shows the
lowest MT compliance, 55%. The difficulty seems to lie
mainly in the large amount of data to be collected, since
the MT had not identified the most interesting key aspects,
and in the fact that this group of patients is managed in
several different wards. Finally, the ICP on Child Delivery
has proven very ineffective, exhibiting very low adherence
with the selected QIs. Various major obstacles have been
identified for this ICP: first of all, the lack of sound scien-
tific evidence supporting the pathway's indications, which
were derived from authoritative sources (WHO) but are
mostly based on expert opinion and remain controversial.
Furthermore, it is believed that the high and rising cesar-
ean section rates in most countries may be due in part to
physician attitudes of defensive medicine. Legal suits are
very frequent when a vaginal delivery has a bad outcome,
but they are unlikely when an unnecessary cesarean sec-
tion is performed [38]. Protection against legal litigation
would thus be required to enhance compliance with
indications aiming to reduce unnecessary cesarean section
rates. Other actions which could help achieve WHO goals
are the provision of epidural anesthesia free of charge (in
most Italian institutions it is rather costly for patients),
and the equalization of financial compensation for CS
and vaginal delivery, since in Italy the former is much
higher and this might encourage some gynecologists to
support the performance of unnecessary CSs.
Conclusion
This research highlights the importance of multidiscipli-
nary involvement in the creation and application of a
strategy to favor EBM introduction into practice. We
believe hospitals should ensure the incorporation of
research into routine practice by systematically applying a
shared, multifaceted strategy, as single interventions can-
not be effective in all situations [2]. Our experience con-
firms what recently emphasized in the literature, i.e. that
multiple approaches are the most effective, and that the
choice of interventions should be guided by the analysis
of determinants of professional behavior and by specific
clinical and organizational circumstances [39]. Health
care institutions willing to adopt analogous tools should
first assess local characteristics carefully and develop a tai-
lor-made approach.
The presence of central coordination, competent in scien-
tific methodology and implementation techniques, is nec-
essary to support the work of individual multidisciplinary
teams, to favor agreement between health care
professionals and managers, and to constantly remind all
parties involved of the importance of the program, as
motivation is likely to decrease with time. A far-reaching
change in culture is essential to favor the acceptance of
change in an organization. Institutions should offer their
professionals adequate training on implementation strat-
egies and on the nature and importance of clinical practice
improvement [40].
The main down side of this program, as emphasized in
the literature on quality improvement strategies [7] is its
high costs in terms of staff time. This can be a cause of
reluctance for some clinicians and managers. However,
the introduction of scientific evidence into practice does
necessarily require time and money. We therefore believe
that, just like for experimental trials, economic and pro-
fessional resources should be allocated to allow the
achievement of this objective.
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